# NEXAPH Review 2026: 10-Vial Kit Model, Frontier Research Compounds & Specialty Peptide Catalog
> Disclaimer: All NEXAPH products listed on Peptides.SO are sold exclusively for laboratory and in-vitro scientific research. They are not approved for human or veterinary use. This review is provided for informational and research-procurement purposes only.
NEXAPH (nexaph.com) is a U.S.-based research peptide supplier with approximately 60 active listings on Peptides.SO, and one of the more architecturally distinctive vendors in the 2026 research peptide market. Rather than selling single vials, NEXAPH structures most of its catalog around 10-vial kit formats — a procurement model that reduces per-mg costs for research programs with sustained compound requirements, ensures compound continuity across extended experimental timelines, and simplifies reorder logistics. The catalog also features several frontier research compounds — Survodutide, ARA-290, Dihexa, VIP, and the proprietary NXP series — that are rarely stocked by domestic U.S. vendors.
Company Overview
NEXAPH positions itself as a quality-documentation-first supplier serving U.S. research programs across growth hormone-axis peptides, GLP receptor agonists, tissue healing compounds, cognitive and neuroprotective peptides, anti-aging and longevity research agents, and specialty frontier compounds. The company's 10-vial kit model differentiates it structurally from single-vial vendors: instead of ordering 10mg in one vial, a researcher orders 10 × 10mg vials (100mg total) at a lower per-mg kit price — a format designed for protocols requiring consistent compound access across multiple experimental runs.
The breadth of frontier compound coverage — including Survodutide (dual GGT/GLP agonist), ARA-290 (non-hematopoietic EPO analog), Dihexa (HGF/c-Met pathway nootropic), VIP (Vasoactive Intestinal Peptide), and the proprietary NXP-2P and NXP-3P series — reflects a catalog curation philosophy oriented toward researchers at the leading edge of peptide pharmacology rather than commodity-tier GHRP/GHRH buyers.
NEXAPH's accessories catalog (metal and wooden vial openers, researcher case storage) further reflects its attention to the full research workflow — small accessories with genuine utility in a peptide research laboratory context.
Catalog Architecture: The 10-Vial Kit Model
NEXAPH's defining catalog feature is the 10-vial kit format. Most peptide compounds are sold in kits of 10 vials, each at the specified per-vial concentration. This creates the following per-mg economics:
| Compound | Kit Price | Vials × Concentration | Total mg | Per-Mg |
|---|---|---|---|---|
| Ipamorelin 10mg | $150 | 10 × 10mg | 100mg | $1.50/mg |
| BPC-157 10mg | $175 | 10 × 10mg | 100mg | $1.75/mg |
| TB-500 (TB4) 10mg | $325 | 10 × 10mg | 100mg | $3.25/mg |
| KPV 10mg | $165 | 10 × 10mg | 100mg | $1.65/mg |
| PT-141 10mg | $165 | 10 × 10mg | 100mg | $1.65/mg |
| Thymosin Alpha-1 10mg | $75 (single) / $325 (kit) | varies | — | — |
| NAD+ 250mg Buffered | $145–$210 | 10 × 250mg | 2500mg | $0.06–$0.08/mg |
The Ipamorelin kit at $1.50/mg and BPC-157 kit at $1.75/mg represent competitive per-mg pricing relative to single-vial vendors at $3–$10/mg for these compounds. Researchers running extended protocols (12+ week studies, multiple cohorts) who can commit to kit-format procurement benefit disproportionately from NEXAPH's pricing structure.
Catalog & Products
Growth Hormone Secretagogue Research
Ipamorelin 10mg (10-Vial Kit at $150 = $1.50/mg): Ipamorelin is the most selective GHS-R1a agonist in the GHRP-class. It produces pulsatile GH release with minimal cortisol or prolactin response — a selectivity profile that makes it the preferred GHRP for research designs requiring isolated GH secretagogue stimulation without stress-hormone confounds. At $1.50/mg (kit pricing), NEXAPH offers one of the most competitive ipamorelin per-mg prices verified among quality-documented U.S. suppliers.
CJC-1295 No DAC 5mg ($170 single vial / additional kit formats): The Modified GRF 1-29 GHRH analog for pulsatile growth hormone-releasing hormone research. CJC-1295 without DAC maintains physiological GHRH receptor signaling kinetics, relevant for studies of pulsatile GH release biology and pituitary somatotroph function.
CJC-No DAC / Ipamorelin Blend (5mg/5mg at $235): The standard GHRH/GHRP research combination, providing complementary GH secretagogue mechanisms in a single vial.
Sermorelin ($195 single): The native GHRH 1-29 analog for foundational GH regulatory biology research. Sermorelin has the most established pharmacological literature of the GHRH analog class.
Tesamorelin ($325–$350, two formats): The 44-amino acid stabilized GHRH analog studied in visceral adipose tissue biology.
GLP Receptor Research
Cagrilintide (10mg at $195–$395, two formats): An amylin analog for GLP-1/amylin combination biology research. The $195 entry-point for the lower kit format makes Cagrilintide accessible relative to vendors pricing this compound at $500+.
Survodutide (10mg at $400): Survodutide is a dual glucagon/GLP-1 receptor co-agonist (GCGR/GLP-1R) — representing frontier metabolic research pharmacology. The GCGR component adds direct hepatic glycogenolysis, enhanced fatty acid oxidation, and thermogenesis biology dimensions that GLP-1 alone does not capture. As of 2026, Survodutide remains in clinical development, with active Phase 2/3 trials in metabolic disease. NEXAPH's domestic U.S. availability of this compound makes it rare among research suppliers.
Semaglutide, Tirzepatide: Available through NEXAPH's catalog for GLP-1 receptor and dual incretin research.
Tissue Healing Research
BPC-157 10mg Kit ($175 = $1.75/mg) and standalone ($210 for 10mg): BPC-157 (Body Protection Compound-157) has been studied in gastrointestinal mucosal healing, tendon repair, angiogenesis, and systemic tissue protection via growth hormone receptor and nitric oxide pathway interactions. The kit pricing at $1.75/mg is notably competitive — single-vial vendors often price BPC-157 at $5–$20/mg. For researchers running multi-week tissue healing studies, the kit format is both logistically efficient and cost-effective.
TB-500 (TB4) 10mg Kit ($325 = $3.25/mg): Thymosin Beta-4 research covers actin-sequestering activity, cell motility promotion, wound healing, and anti-inflammatory signaling. The TB4-Frag 17-23 10mg kit ($175) provides the active actin-binding domain fragment specifically.
KLOW Blend ($475 for 10-vial kit): BPC-157/TB-500/KPV/GHK-Cu combination in the 10-vial kit format for researchers running multi-compound tissue repair studies at scale.
KPV 10mg Kit ($165 = $1.65/mg): The α-MSH anti-inflammatory tripeptide at competitive kit pricing for mucosal biology and NF-κB pathway research.
Cognitive & Neuroprotective Research
Semax and Selank (multiple formats): Both the synthetic ACTH analog Semax (for BDNF/NGF upregulation and neuroprotective research) and the tuftsin analog Selank (for anxiolytic and GABAergic signaling research) are available in single-vial and kit formats.
Dihexa 10mg (100 Tablets at $350): Dihexa (PNB-0408) is a synthetic hexapeptide analogue of angiotensin IV, studied for cognitive enhancement through HGF (Hepatocyte Growth Factor) / c-Met receptor pathway activation. Research in rodent models demonstrated effects on synaptic plasticity, memory consolidation, and neurogenesis at concentrations substantially lower than typical BDNF-activating approaches. Dihexa's oral bioavailability and blood-brain barrier penetrance make it a research tool for studying non-TrkB neurotrophin-pathway cognitive biology. The 100-tablet format at $3.50/tablet is unusual in the research peptide market.
VIP (Vasoactive Intestinal Peptide) 10mg Kit ($225–$425): VIP is a 28-amino acid neuropeptide studied across an unusually broad range of biological functions:
- •Neuromodulation: VIP is a co-transmitter in parasympathetic and enteric nervous system neurons, studied in autonomic nervous system biology and circadian rhythm regulation (through VIP-expressing neurons of the suprachiasmatic nucleus)
- •Immunomodulation: VIP receptors VPAC1 and VPAC2 are expressed on T cells, B cells, macrophages, and dendritic cells; VIP exerts anti-inflammatory effects via cAMP-mediated inhibition of pro-inflammatory cytokines
- •Pulmonary research: VIP is a potent bronchodilator and vasodilator with research applications in pulmonary hypertension and asthma biology
- •Gastrointestinal: VIP regulates intestinal secretion and motility; it is the peptide whose deficiency causes the VIPoma research syndrome
VIP availability from a domestic U.S. source is unusual, and NEXAPH's two kit formats at $225 and $425 cover both entry-level and sustained research program needs.
ARA-290 (Cibinetide) ($325): ARA-290 is an 11-amino acid cyclic peptide derived from the Helix B surface peptide region of erythropoietin (EPO), engineered to activate the innate repair receptor (IRR — a heterodimer of EPO receptor and CD131) without activating the hematopoietic EPO receptor. This pharmacological separation enables research into EPO's neuroprotective, anti-inflammatory, and tissue repair signaling without erythropoietic confounds. ARA-290 research has examined peripheral neuropathy, pain, inflammatory biology, and tissue healing in models where hematopoietic EPO receptor activation would complicate data interpretation.
Anti-Aging & Longevity Research
EPITALON ($165): The synthetic telomere/telomerase biology research tetrapeptide for pineal and anti-aging research.
MOTS-c ($160): Mitochondria-derived peptide for AMPK/glucose metabolism research.
NAD+ 250mg Buffered Kit ($145–$210): NAD+ cofactor research in cellular energy metabolism, sirtuin activation, and DNA repair biology. The "Buffered" format may indicate a stabilized presentation; researchers should confirm formulation specifications.
5-Amino-1MQ ($300): NNMT inhibitor for NAD+ pathway and adipocyte biology research.
AOD-9604 ($120): Growth hormone Fragment 176-191 for lipolysis pathway research.
Cosmetic Science & Specialty Peptides
AHK-Cu Cosmetic/Topical 5 × 1g Ampules ($110–$175, two formats): AHK-Cu (Alanine-Histidine-Lysine copper complex) is a tripeptide-copper complex related to but distinct from GHK-Cu, studied for collagen stimulation and wound healing in dermal biology. The 5×1g ampule format (5000mg total) provides a very high-volume format for large-scale cosmetic-science or cell culture studies.
GHK-Cu Lyophilized Kit (10 Vials at $125): GHK-Cu (Copper Tripeptide-1) in the standard kit format.
SNAP-8 10mg ($130 = $13/mg): SNAP-8 (Acetyl Glutamyl Heptapeptide-3) is an octapeptide cosmetic research compound studied as a competitive inhibitor of the SNARE protein complex formation at the neuromuscular junction. Research has examined SNAP-8's potential as a non-injectable alternative to botulinum toxin in cosmetic-science contexts, with hypothesized effects on facial muscle contraction-related skin line formation. The compound is studied for its mechanism of action in synaptic vesicle fusion inhibition at the cosmetic-science research level.
DSIP (Delta Sleep-Inducing Peptide) 5mg ($65): A nine-amino acid neuropeptide originally isolated from rabbit cerebral venous blood during slow-wave sleep. DSIP research has examined its effects on sleep regulation, stress response systems, and antioxidant activity. At $65 for 5mg ($13/mg), this is one of the more accessible DSIP price points.
Beauty Blend (GHK-Cu/KPV, 50mg/20mg) 10-Vial Kit ($375): The cosmetic peptide dual-formulation kit for dermal healing and anti-inflammatory biology research.
GLOW Blend Kit ($425–$475): Multi-compound longevity/tissue blend in the 10-vial format.
Proprietary NXP Series
NXP-2P (multiple formats at $150–$575): The NXP-2P compound is a proprietary NEXAPH designation — researchers should contact NEXAPH directly for the precise active molecule identity and research application scope. The multi-tier pricing ($150 entry through $575 highest volume) suggests differentiated kit sizes.
NXP-3P (Pre-Order, 48mg kit at $210–$1,000): The pre-order status of NXP-3P suggests a newer compound being introduced to the catalog. The 48mg kit format and $210–$1,000 pricing range across kit sizes indicates a premium specialty compound. Researchers interested in the NXP series should contact NEXAPH for compound identification and research characterization data.
PDA 10mg Kit ($165): A proprietary designation; researchers should verify the underlying compound with NEXAPH before research use.
Accessories
NEXAPH offers three accessor items that reflect a full-workflow research orientation:
- •Nexaph Signature Wooden Bottle Opener ($20): Premium accessory for lyophilized vial access
- •Nexaph Black Steel Bottle Opener ($12)
- •Nexaph Small Metal Vial Opener — Matte Black ($12)
- •LIPO-C with B12 ($225): Injectable lipotropic-B12 combination for metabolic research
Quality & Testing
NEXAPH applies third-party analytical testing standards across its catalog: HPLC purity characterization and mass spectrometry identity confirmation per production batch, with COA documentation available to purchasing researchers. The 10-vial kit model means that batch consistency is critical — a kit of 10 vials should all derive from the same synthesized and tested batch.
For frontier compounds (Survodutide, ARA-290, Dihexa, NXP series), COA documentation should cover both purity percentage and molecular identity confirmation, given that synthesis complexity and novelty of these compounds creates greater quality variance risk than established commodity peptides. Researchers acquiring these compounds should specifically request and verify COA data before experimental use.
Shipping & Customer Service
NEXAPH ships domestically within the United States with 1–3 business day processing. The 10-vial kit format (more compound per shipment) may affect shipping weight and cold-chain requirements relative to single-vial orders. Lyophilized kits ship with appropriate insulation for short-transit temperature stability, with refrigeration on receipt the standard recommendation.
The proprietary NXP series and specialty compounds (ARA-290, VIP, Dihexa) require customer service capable of addressing compound-specific technical questions. Researchers planning to use these frontier compounds should contact NEXAPH for research characterization data and reconstitution guidance.
Pros & Cons
Pros
- •10-Vial kit model reduces per-mg cost significantly (Ipamorelin at $1.50/mg, BPC-157 at $1.75/mg)
- •Frontier compound availability: Survodutide, ARA-290, Dihexa, VIP — rare in domestic market
- •SNAP-8 for cosmetic-science SNARE inhibition research
- •AHK-Cu 5×1g ampule bulk format for high-volume cosmetic-science research
- •Both NAD+ and 5-Amino-1MQ for complementary NAD+ pathway research
- •DSIP for sleep biology research
- •NXP proprietary series for researchers working on novel compound development
- •Wooden and metal bottle openers for full-workflow procurement convenience
- •Beauty Blend and GLOW Blend in 10-vial kit format
Cons
- •Kit model requires higher upfront commitment per compound
- •Tiered and multiple-format pricing can be confusing (NXP series has 6+ price points)
- •NXP-2P, NXP-3P, and PDA designations lack publicly available compound identity information
- •No dedicated GHRP series (GHRP-2, GHRP-6, Hexarelin) listed in current catalog
- •Survodutide and ARA-290 at $325–$400 reflect frontier compound premium pricing
Verdict
NEXAPH earns a strong recommendation for researchers who can commit to the kit-format procurement model and value access to frontier research compounds unavailable from most domestic U.S. suppliers. The $1.50/mg Ipamorelin and $1.75/mg BPC-157 kit pricing provide best-in-class per-mg economics for researchers running sustained protocols.
The frontier compound catalog — Survodutide (GCGR/GLP-1R), ARA-290 (IRR/non-hematopoietic EPO), Dihexa (HGF/c-Met), VIP (VPAC1/VPAC2 neuroimmune), and SNAP-8 (SNARE inhibition cosmetic science) — makes NEXAPH the strongest domestic U.S. option for research programs working outside the standard GH-axis and tissue-healing compound categories. If your research program includes any of these less-common pharmacological targets, NEXAPH may be the only domestic single-source option.
Researchers who need single-vial flexibility or who primarily work with commodity GHRP compounds may find other vendors' pricing structures more suitable. But for sustained-protocol and frontier-compound research, NEXAPH's kit model and specialty catalog are genuinely differentiated.
---
For research purposes only. Not for human use. All products are sold exclusively for in-vitro laboratory research.
Internal links: Ipamorelin • BPC-157 • TB-500 • Sermorelin • Semaglutide • GHK-Cu • Semax • Compare suppliers